NHS dental costs lower for gum disease with non-antibiotic drugs
A UK dental hospital compared antibiotic and non-antibiotic costs for treating periodontitis (gum disease). Non-antibiotic drugs like metformin cost substantially less than antibiotics, though effectiveness was not evaluated.
Why it matters: Gum disease treatment could become cheaper while reducing unnecessary antibiotic use, a public health priority.
Keep in mind: This study examined acquisition costs only, not whether non-antibiotic treatments actually work or produce better patient outcomes.
AI-assisted explanation based on the supplied abstract. Read the linked source for full context.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 18, 2026 · Discovered: Sep 19, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Observational
- Sample size
- 643
- Duration
- 36 months
- Population
- Antibiotic prescriptions issued at Charles Clifford Dental Hospital for periodontitis treatment
- Primary outcome
- NHS acquisition costs of systemic antimicrobial and non-antimicrobial adjuncts for periodontal therapy
- Effect size
- Azithromycin: 55.16% cost reduction compared to A+M; Metformin 500 mg: up to 91.46% cost reduction
- Significance
- Not reported
- Journal
- British Dental Journal
- Published
- Sep 18, 2026
Sources
Primary source
- British dental journal ↗Peer reviewed
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.